NCT01635829View on ClinicalTrials.gov

A Study to Investigate the Potential Pharmacokinetic Interactions Between Phenytoin or Carbamazepine and Telaprevir

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

August 31, 2012

Study Completion Date

September 30, 2012

Conditions
Healthy Participants
Interventions
DRUG

Telaprevir

Type=exact number, unit=mg, number=375, form=tablet, route=oral. Two tablets of telaprevir will be administered as per the dosing regimens for each part of both the panels.

DRUG

Phenytoin

Type=exact number, unit=mg, number=100, form=capsule, route=oral. Two capsules of phenytoin will be administered as per the dosing regimen in Part 2 of Panel 1.

DRUG

Carbamazepine

Type=exact number, unit=mg, number=200, form=tablet, route=oral. One tablet of carbamazepine will be administered as per dosing regimen in Part 2 of Panel 2.

Trial Locations (1)

Unknown

Groningen

All Listed Sponsors
lead

Janssen Infectious Diseases BVBA

INDUSTRY

NCT01635829 - A Study to Investigate the Potential Pharmacokinetic Interactions Between Phenytoin or Carbamazepine and Telaprevir | Biotech Hunter | Biotech Hunter